Kyverna Therapeutics, Inc. KYTX
4.37 USD -0.11 (-2.46%)
Regular-session close
4.89 +0.52 +12.00%
After hours · Nov 19, 4:00 PM ET
4.30 Day range 4.62
4.30 52-week range 13.67
- YTD
- -53.51%
- 1 year
- -46.90%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -169.83M | -142.60M | -62.41M | -29.38M | -26.35M | |
| -161.31M | -127.48M | -60.37M | -28.89M | -26.35M | |
| -3.64 | -3.33 | -89.61 | -63.43 | -99.10 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 124.64M | 97.17M | 35.21M | 38.29M | 76.62M | |
| 293.83M | 304.64M | 75.19M | 66.92M | 85.49M | |
| 61.55M | 38.06M | 26.02M | 20.25M | 23.02M | |
| 29.03M | 8.24M | 9.08M | 10.56M | 5.55M | |
| 232.28M | 266.59M | -131.40M | -74.00M | -46.25M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -153.71M | -114.25M | -52.41M | -36.11M | -22.16M | |
| 40.02M | -160.90M | -8.79M | -14.10M | -1.29M | |
| 141.17M | 337.11M | 58.12M | 11.88M | 72.52M | |
| -1.06M | -2.21M | -621.00K | -768.00K | -1.29M | |
| 27.47M | 61.96M | -3.08M | -38.33M | 49.08M |
